Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

Masimo CorporationNASDAQ: MASI

Investing Cash Flow · Q1 FY2026 · quarter ended Apr 2026

Investing cash flow turns negative

Q1 FY2026 investing cash flow was -$4.2M, compared with $10.7M a year earlier. Trailing-twelve-month investing cash flow was $260.2M.

Context

  • Investing cash flow amounted to 18.0% of revenue in FY2025, up 15.6 pp from a year earlier.
  • Investing cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly investing cash flow holds near -$4.2M or moves back toward the trailing-twelve-month quarterly average of $65.05M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
-$4.2M-51.7% QoQ
Last fiscal yearJan 2026
$275.1M+637.3% YoY
LTMApr 2026
$260.2M+1304.6% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-139.3%——
1 year+637.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
275.1M USD
Year-over-year change
+637.3%

Investing Cash Flow vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1304.6% is the highest of 11, against a peer median of -26.8%.
  • Investing cash flow amounts to 16.7% of revenue for MASI, versus a peer median of 8.3%.
MASI Competitors
Investing Cash Flow for MASI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAXBaxter International Inc.LTM Jun 2026$825M USD-129.7%—7.2%
HSICHenry Schein, Inc.LTM Jun 2026$331M USD-16.0%+20.0%2.4%
ATRAptarGroup, Inc.LTM Jun 2026$325.43M USD-13.9%+3.8%8.3%
STVNStevanato Group S.p.A.LTM Jun 2026€275.23M EUR-37.5%+2.6%22.5%
MASIMasimo CorporationLTM Apr 2026$260.2M USD+1304.6%—16.7%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$237.1M USD+19.3%-46.0%9.2%
RGENRepligen CorporationLTM Jun 2026$222.6M USD+45.9%+8.6%28.4%
AVTRAvantor, Inc.LTM Jun 2026$143M USD-131.1%+6.0%2.2%
MOHMolina Healthcare, Inc.LTM Sep 2026$98M USD-197.0%—0.2%
RYTMRhythm Pharmaceuticals, Inc.LTM Sep 2026$85.31M USD+158.3%—30.4%
ABVXAbivax S.A.FY2025€13.18M EUR-183.6%+3.1%—
Peer median (excluding MASI) —-26.8%+3.8%8.3%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Net Income229.6M143.5M81.5M(304.9M)(151.5M)
Depreciation & Amortization35.6M136.1M98.3M103M38.8M
Deferred Income Tax(15.1M)(39.3M)(35.6M)(38.2M)11.8M
Stock-Based Compensation44.7M47.7M7M41.5M35.8M
Change in Working Capital(31.5M)(261.8M)(70.9M)(10.7M)(89.9M)
Accounts Receivables(76.9M)(151.3M)91.9M(60.2M)17.2M
Inventory13.5M(155.9M)(69.2M)(7.5M)(112.1M)
Accounts Payables11M60.5M(19.6M)14.8M(27.1M)
Other Working Capital20.9M(15.1M)(74M)42.2M32.1M
Other Non-Cash Items1.3M3.2M13.8M405.7M372.2M
Operating Cash Flow264.6M29.4M94.1M196.4M217.2M
Capital Expenditures(34.9M)(56.3M)(87.7M)(51.1M)(19.4M)
Acquisitions (Net)0(999.7M)7.5M00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(12M)(5.2M)(44.7M)(31.2M)294.5M
Investing Cash Flow(37.5M)(1.06B)(81.2M)(51.2M)275.1M
Debt Repayment0939.2M(51.2M)(146.8M)(207.8M)
Common Stock Issued23.2M8.1M7M25.2M71.4M
Common Stock Repurchased(128.9M)(401.5M)00(363.7M)
Dividends Paid00000
Other Financing Activities(16.7M)(25.4M)(12.9M)(4M)(20.6M)
Financing Cash Flow(122.4M)520.4M(57.1M)(125.6M)(520.7M)
Effect of Forex Changes(1.3M)(30.9M)2.8M(6.4M)53.8M
Net Change in Cash103.4M(538.8M)(41.4M)13.2M26M
Free Cash Flow229.7M(26.9M)6.4M145.3M197.8M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.